| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 52 | 91 | 44 | 45 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 52 | 91 | 44 | 45 | | | Operating Expenses | | Research Development | 514 | 387 | 266 | 216 | | Selling General and Administrative | 421 | 2,385 | 430 | 500 | | Non Recurring | (4) |
-
|
-
|
-
| | Others | 5 | 4 | 4 | 13 | | | | Total Operating Expenses | 936 |
-
|
-
|
-
| | | | Operating Income or Loss | (889) | (2,685) | (655) | (683) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,168 | (1,703) | 73 | (1,845) | | Earnings Before Interest And Taxes | (397) | (4,387) | (582) | (2,528) | | Interest Expense |
-
| 1,146 | 74 | 62 | | Income Before Tax | (397) | (5,533) | (656) | (2,589) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (397) | (5,533) | (656) | (2,589) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (397) | (5,533) | (656) | (2,589) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($397) | ($5,533) | ($656) | ($2,589) |
|
0.03% Nasdaq 0.00%
Income Statement
